Reaction Details Report a problem with these data
Target
Glycoprotein 42
Ligand
BDBM50019
Substrate
n/a
Meas. Tech.
Dose Response Confirmation for Small Molecule Inhibitors of Epstein-Barr Virus
IC50
9800±n/a nM
Citation
 PubChem, PC Dose Response Confirmation for Small Molecule Inhibitors of Epstein-Barr Virus PubChem Bioassay (2008)[AID] 
Target
Name:
Glycoprotein 42
Synonyms:
BZLF2 | GP42_EBVA8
Type:
Enzyme Catalytic Domain
Mol. Mass.:
25424.12
Organism:
Human herpesvirus 4 type 2
Description:
gi_139424501
Residue:
223
Sequence:
MVSFKQVRVPLFTAIALVIVLLLAYFLPPRVRGGGRVSAAAITWVPKPNVEVWPVDPPPPVNFNKTAEQEYGDKEIKLPHWTPTLHTFQVPKNYTKANCTYCNTREYTFSYKERCFYFTKKKHTWNGCFQACAELYPCTYFYGPTPDILPVVTRNLNAIESLWVGVYRVGEGNWTSLDGGTFKVYQIFGSHCTYVSKFSTVPVSHHECSFLKPCLCVSQRSNS
  
Inhibitor
Name:
BDBM50019
Synonyms:
2-(1,3-dihydrobenzimidazol-2-ylidene)-4-[(5,7-dimethyl-[1,2,4]triazolo[4,3-a]pyrimidin-3-yl)sulfanyl]-3-oxidanylidene-butanenitrile | 2-(1,3-dihydrobenzimidazol-2-ylidene)-4-[(5,7-dimethyl-[1,2,4]triazolo[4,3-a]pyrimidin-3-yl)sulfanyl]-3-oxobutanenitrile | 2-(1,3-dihydrobenzimidazol-2-ylidene)-4-[(5,7-dimethyl-[1,2,4]triazolo[4,3-a]pyrimidin-3-yl)thio]-3-keto-butyronitrile | 2-(1,3-dihydrobenzimidazol-2-ylidene)-4-[(5,7-dimethyl-[1,2,4]triazolo[4,3-a]pyrimidin-3-yl)thio]-3-oxobutanenitrile | MLS000057091 | SMR000064178 | cid_5643743
Type:
Small organic molecule
Emp. Form.:
C18H15N7OS
Mol. Mass.:
377.423
SMILES:
Cc1cc(C)n2c(SCC(=O)C(C#N)c3nc4ccccc4[nH]3)nnc2n1
Structure:
Search PDB for entries with ligand similarity: